Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: | Afluria Quad |
Active Ingredients: |
Influenza virus A/Hong Kong/2671/2019 (H3N2) - like virus 15mcg |
Dosage Form: | Suspension for injection |
New Zealand Sponsor: | Seqirus (NZ) Limited |
Manufacturers: |
Seqirus Pty Limited, Melbourne, Australia |
Product: | Afluria Quad Junior |
Active Ingredients: |
Influenza virus A/Hong Kong/2671/2019 (H3N2) - like virus 7.5mcg |
Dosage Form: | Suspension for injection |
New Zealand Sponsor: | Seqirus (NZ) Limited |
Manufacturer: | Seqirus Pty Limited, Melbourne, Australia |
Dated this 26th day of March 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).